Objective To investigate the neuroprotective effects of transplantation of glial cell-derived trophic factor (GDNF) gene-modified neural stem cells (NSCs) on temporary cerebral ischemia in rats. Methods Primary neonatal rat NSCs were transfected with GDNF plasmid (GDNF/NSCs). After 7 days they were induced to differentiate, immunohistochemistry staining was used to detect the expression of MAP2+ positive cells. Rats were subjected to two-hour middle cerebral artery occlusion and reperfusion, followed by infusion of saline, NSCs or GDNF/NSCs after reperfusion respectively. All rats were sacrificed at 1, 2, 3, 5, and 7 weeks after reperfusion. Immunohistochemistry staining was performed to identify the neuronal differentiation from implanted cells and to assess glia limitans perivascularis formed by astrocyte. Luxol fast blue（LFB）staining was used to observe nerve fiber damages. Results MAP2+ cells from GDNF/NSCs were higher than those from NSCs in vitro. Implanted cells differentiated into MAP2+ cells, which reached the peak at 5 weeks after reperfusion. MAP2+ cells from grafted GDNF/NSCs at 3~7 weeks after reperfusion were higher than those from grafted NSCs. The glia limitans perivascularis in ischemic areas encountered varying degrees of damages in all groups, and the damages in control group at different time points were serious, while the damages in two transplantation groups were gradually repaired over time, and the repair in GDNF/NSCs group was earlier than that in NSCs group. Furthermore, the recovery of nerve fiber in GDNF/NSCs group was stronger than that in NSCs group. Conclusions GDNF/NSCs provide better neuroprotective effect for temporary cerebral ischemia than NSCs, which may be related to GDNF enhancing neuronal differentiation and restoration on glia limitans and nerve fibers of NSCs.
Key words
Neural stem cells; Gene therapy; Glial cell line derived neurotrophic factor; Stroke /
Glia limitans
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Gao XQ, Wu DD, Dou L, et al. Protective effects of mesenchymal stem cells overexpressing extracellular regulating kinase 1/2 against stroke in rats[J]. Brain Res Bull, 2019, 149: 42-52.
[2] Chen B, Gao XQ, Yang CX, et al. Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats[J]. Brain Res, 2009, 1284: 1-11.
[3] Beck KD, Valverde J, Alexi T, et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomyinduced degeneration in the adult brain[J]. Nature, 1995, 373(6512): 339-341.
[4] Kobayashi T, Ah1enius H, Thored P, et al. Intracere bralinfusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats[J]. Stroke, 2006, 37(9): 2361-2367.
[5] Rakowicz WP, Staples CS, Milbrandt J, et al. Glial cell line-derived neurotrophic factor promotes the survival of early postnatal spinal motor neurons in the lateral and medial motor columns in slice culture [J]. J Neurosci, 2002, 22(10): 3953-3962.
[6] Duarte EP, Curcio M, Canzoniero LM, et al. Neuroprotection by GDNF in the ischemic brain[J]. Growth Factors, 2012, 30(4): 242-257.
[7] Liu YN, Wang SW, Luo SJ, et al. Intravenous PEP-1-GDNF is protective after focal cerebral ischemia in rats[J]. Neuroscience Lett, 2016, 617: 150-155.
[8] Yang CX, Zhou L, Gao XQ, et al. Neuroprotective effects of bone marrow stem cells overexpressing glial cell line-derived neurotrophic factor on rats with intracerebral hemorrhage and neurons exposed to hypoxia/reoxygenation[J]. Neurosurgery, 2011, 68(3): 691-704.
[9] Qin C, Fan WH, Liu Q, et al. Fingolimod protects against ischemic white matter damage by modulating microglia toward M2 polarization via STAT3 pathway[J]. Stroke, 2017, 48(12): 3336-3346.
[10]Wang Y, Liu G, Hong D, et al. White matter injury in ischemic stroke[J]. Prog Neurobiol, 2016, 141: 45-60.
[11]Wang X, Min S, Xie F, et al. Glial cell-derived neurotrophic factor alleviates sepsis-induced neuromuscular dysfunction by decreasing the expression of γ- and α7-nicotinic acetylcholine receptors in an experimental rat model of neuromyopathy[J]. Biochem Biophys Res Commun, 2018, 496(2): 260-266.
[12]Blesch A, Tuszynski MH. Cellular GDNF delivery promotes growth of motor and dorsal column sensory axons after partial and complete spinal cord transections and induces remyelination[J]. J Comp Neurol, 2003, 467(3): 403-417.
[13]Zhang LQ, Ma ZW, Smith GM, et al. GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons[J]. Glia, 2009, 57(11): 1178-1191.
[14]Gao XQ, Deng L, Wang Y, et al. GDNF enhances therapeutic efficiency of neural stem cells-based therapy in chronic experimental allergic encephalomyelitis in rat[J]. Stem Cells Int, 2016, 2016: 1431349.
[15]Barreda-Manso MA, Yanguas-Casás N, Nieto-Sampedro M, et al. Neuroprotection and blood-brain barrier restoration by Salubrinal after a cortical stab injury[J]. J Cell Physiol, 2017, 232(6): 1501-1510.
[16]Shimizu F, Sano Y, Saito K, et al. Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier[J]. Neurochem Res, 2012, 37(2): 401-409.
